Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts under ‘Medical Sales Jobs’

TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System

New LipiFlow® System Provides Enhanced Graphical User Interface and Ability to Perform Bilateral Treatment from a Single Device MORRISVILLE, N.C.–(Healthcare Revenue & Marketing Network)– TearScience, Inc., a privately-held pharmaceutical device company, t…
Devices, Ophthalmology, FDA
TearScience, LipiFlow, Thermal Pulsation System, dry eye

Dendreon Announces CEO and Chairman Succession Plan

John H. Johnson Elected President, Chief Executive Officer and Chairman-Elect, Dr. Mitchell H. Gold Elected Executive Chairman Company to Hold Conference call Today at 9:00 a.m. ET/6:00 a.m. PT SEATTLE–(Healthcare Sales & Marketing Network)– Febr…
Biopharmaceuticals, Personnel
Dendreon

ISO 9001:2008 and ISO 13485:2003 Certifications for Vita Needle Company

NEEDHAM, MA — (Healthcare Sales & Marketing Network) — Vita Needle Company recently celebrated dual certifications of its Quality Management Systems to the latest general ISO 9001:2008 and clinical device manufacturing standards ISO 13485:2003. In addit…
Devices, Regulatory
Vita Needle

Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections

Conformable GORE® TAG® Thoracic Endoprosthesis Designed for Endovascular Repair of the Descending Thoracic Aorta Provides Conformability without Compromise FLAGSTAFF, Ariz.–(Healthcare Sales & Marketing Network)– W. L. Gore & Associates, Inc. …
Devices, FDA
W. L. Gore, Conformable GORE TAG, Thoracic Endoprosthesis, endovascular repair

Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections

Conformable GORE® TAG® Thoracic Endoprosthesis Designed for Endovascular Repair of the Descending Thoracic Aorta Provides Conformability without Compromise FLAGSTAFF, Ariz.–(Healthcare Sales & Marketing Network)– W. L. Gore & Associates, Inc. …
Devices, FDA
W. L. Gore, Conformable GORE TAG, Thoracic Endoprosthesis, endovascular repair

Terumo Cardiovascular Systems Becomes Exclusive U.S. Distributor for TigerPaw(R) System II, Left Atrial Appendage Closure Device

ANN ARBOR, Mich., Jan. 19, 2012 (HSMN NewsFeed) — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx, Inc. to distribute the TigerPaw® System II, a left atrial appendage closure device in the U.S….
Devices, Cardiology, Distribution
Terumo Cardiovascular Systems, LAAx, TigerPaw System, left atrial appendage

Terumo Cardiovascular Systems Becomes Exclusive U.S. Distributor for TigerPaw(R) System II, Left Atrial Appendage Closure Device

ANN ARBOR, Mich., Jan. 19, 2012 (HSMN NewsFeed) — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx, Inc. to distribute the TigerPaw® System II, a left atrial appendage closure device in the U.S….
Devices, Cardiology, Distribution
Terumo Cardiovascular Systems, LAAx, TigerPaw System, left atrial appendage

diaDexus, Inc. Names Jean-Frederic Viret, Ph.D. Chief Financial Officer

SOUTH SAN FRANCISCO, Calif., Jan. 18, 2012 (HSMN NewsFeed) — diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced t…
Diagnostics, Personnel
diaDexus

Cytomedix Appoints Cathryn Hope as Vice President of Marketing

GAITHERSBURG, MD–(Healthcare Revenue & Product management Network)- Cytomedix, Inc. (OTC.BB: CMXI.OB ) (the "Company"), a top developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the app…
Regenerative Medicine, Personnel
Cytomedix

ULURU Inc. Completes Altrazeal(R) License Agreement for Europe

Altrazeal® Marketing Company Established Product Launch Anticipated in Germany, Australia and New Zealand Second Quarter 2012 ADDISON, Texas, Jan. 17, 2012 (HSMN NewsFeed) — ULURU Inc. (NYSE AMEX: ULU), announced today that the License Agreeme…
Devices, Wound Care, Licensing
ULURU, Melmed Holdings, Altrazeal, wound dressing